Viral vector vaccines

Viral vector vaccines

Over the past two years, the SARS-CoV-2 pandemic has highlighted the impact that emerging pathogens can have on global health. The development of new and effective vaccine technologies is vital in the fight against such threats. Viral vectors are a relatively new vaccine platform that relies on reco...

Descripció completa

Dades bibliogràfiques
Autors principals:	McCann, N, O'Connor, D, Lambe, T, Pollard, AJ
Format:	Journal article
Idioma:	English
Publicat:	Elseveir 2022

Ítems similars

Clinical advances in viral-vectored influenza vaccines
per: Sebastian, S, et al.
Publicat: (2018)

Clinical Advances in Viral-Vectored Influenza Vaccines
per: Sarah Sebastian, et al.
Publicat: (2018-05-01)

Clinical development of viral vectored vaccines against MERS-COV
per: Ewer, K, et al.
Publicat: (2018)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
per: Sheerin, D, et al.
Publicat: (2021)

Viral vectors as vaccine platforms: from immunogenicity to impact
per: Ewer (nee Russell), K, et al.
Publicat: (2016)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
per: Green, C, et al.
Publicat: (2023)

Towards paratyphoid control: the vital role of the challenge model
per: McCann, N, et al.
Publicat: (2024)

Viral vectors for malaria vaccine development.
per: Li, S, et al.
Publicat: (2007)

Characterizing vaccine responses using host genomic and transcriptomic analysis.
per: O'Connor, D, et al.
Publicat: (2013)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
per: Sheerin, D, et al.
Publicat: (2022)

Developing viral vectored vaccines for MAGE-expressing tumours
per: McAuliffe, J
Publicat: (2020)

The use of viral vectors in vaccine development
per: Tatianna Travieso, et al.
Publicat: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
per: Kenneth Lundstrom
Publicat: (2016-11-01)

Developments in Viral Vector-Based Vaccines
per: Takehiro Ura, et al.
Publicat: (2014-07-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
per: Bissett, C, et al.
Publicat: (2024)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
per: Dylan Sheerin, et al.
Publicat: (2021-10-01)

Utilization of Viral Vector Vaccines in Preparing for Future Pandemics
per: Kimberly A. Hofmeyer, et al.
Publicat: (2022-03-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
per: Arunkumar, G, et al.
Publicat: (2019)

Viral vectors as vaccine platforms: Deployment in sight
per: Rollier, C, et al.
Publicat: (2011)

Viral vectors as vaccine platforms: deployment in sight.
per: Rollier, C, et al.
Publicat: (2011)

Viral Vectors for COVID-19 Vaccine Development
per: Kenneth Lundstrom
Publicat: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
per: Luis Jiménez-Cabello, et al.
Publicat: (2020-12-01)

Novel viral vector vaccines for tropical infections
per: Rampling, T
Publicat: (2017)

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines
per: Naina McCann, et al.
Publicat: (2024-08-01)

The use of systems biology and immunological big data to guide vaccine development.
per: Blohmke, C, et al.
Publicat: (2015)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
per: McMahon, M, et al.
Publicat: (2019)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
per: Kapulu, MC
Publicat: (2014)

RNA2HLA: HLA-based quality control of RNA-seq datasets
per: Chelysheva, I, et al.
Publicat: (2021)

Vaccinating the Vulnerable: How Do We Protect Those Experiencing Homelessness?
per: Lucy Jane McCann
Publicat: (2021-08-01)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
per: Tully, C, et al.
Publicat: (2017)

Research advances in replication-deficient viral vector vaccines
per: Junna Wang, et al.
Publicat: (2025-03-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
per: Dulce Mata-Espinosa, et al.
Publicat: (2023-10-01)

Baculovirus expression vector system for production of viral vaccines /
per: 300419 Vlak, J. M., et al.

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
per: Marta Ulaszewska, et al.
Publicat: (2023-01-01)

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
per: Pischedda, S, et al.
Publicat: (2021)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak.
per: McCann, L, et al.
Publicat: (2013)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak
per: McCann, L, et al.
Publicat: (2013)

Searching for the human genetic factors standing in the way of universally effective vaccines.
per: Mentzer, A, et al.
Publicat: (2015)

The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies
per: Drury, R, et al.
Publicat: (2019)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
per: Ewer (nee Russell), K, et al.
Publicat: (2017)